Latest Reports

The “2020 Refractive Surgery Market Report” analyzes the global refractive and presbyopia-correcting market, identifying important trends and key factors for future success. It focuses on the 2020 refractive and presbyopia-correcting surgical market and forecasts market growth and evolution over the next five years. Included are discussions and market estimates for LASIK, lenticular extraction, phakic IOLs, corneal inlays, refractive lens exchange (RLE), and other technologies that may disrupt the market.

The “2021 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success. 

This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs.

On October 30, 2020, Market Scope invited 891 US ophthalmologists via our online survey portal to participate in part seven of a nine-part series of surveys to capture the impact of COVID-19 on ophthalmic practices. There were 117 participants, representing 33 states. This survey attracted a diverse group of doctors; 85 percent of respondents provide cataract surgery, 63 percent perform glaucoma surgery, 29 percent treat retina patients, and 31 percent provide cornea treatment. Most of these doctors offer multiple areas of treatment. All individual responses are kept strictly confidential, and we report only aggregate data.

Market Scope has published the Ophthalmic Market Perspectives (OMP) newsletter for more than 20 years. The newsletter provides the latest business information that is shaping ophthalmic markets and professions. Our articles explore new technologies and company developments. We offer opinions on issues facing the industry. We also analyze and chart quarterly industry data, and we forecast market performance over time.

The report provides a comprehensive analysis of the 2021 global market for ophthalmic surgical instruments—both reusable and disposable—and forecasts market performance over the next five years. Important trends, market drivers, and key factors for future success are discussed. The report offers an overview of ophthalmic surgeries and surgery volume worldwide, as well as an in-depth look at providers of cataract surgery, the most commonly performed ophthalmic surgery. 

The “2021 Cornea Products Market Report” provides an overview of corneal diseases and provides estimates for the populations in six disease categories. The report discusses cornea products and treatments and revenue forecasts for cornea transplants, therapeutic lenses, PTK, intrastromal corneal ring segments, and corneal crosslinking. It also discusses organ donation policy, regulations, and the role of cornea specialists, eye banks, and other organizations.

This report considers over 70 products from more than 50 companies in its market forecasts and discusses the upcoming pipeline of new technologies that have yet to recognize revenue. Hundreds of eye banks, research institutes, and NGOs are also considered. Also included are 14 in-depth company profiles on key market players.

The 2021 edition of Market Scope’s “Premium Cataract Surgery Market Report” is designed to provide insight into the most important premium cataract surgery (PCS) markets in the world. We’ve selected and profiled 13 countries that collectively account for 82 percent of global PCS revenue and provided a deep dive into each of these markets. Ranked by PCS market size, they are: the US, Japan, China, Brazil, South Korea, India, Germany, France, Canada, Australia, Spain, Italy, and the UK.

It is our perception that companies planning to market premium cataract surgery devices often have only a general understanding of the size and characteristics of these key country markets. For each of these countries, we focus on specific characteristics considered vital to the understanding of the PCS opportunities there.

The report forecasts manufacturer and provider revenues for 2020 through 2026 for toric IOLs, PC-IOLs, adjustable IOLs, FLACS, FLACS LRI, manual LRI, and excimer IOL enhancements. It also includes a summary of PCS market drivers such as technology advancements, public PCS awareness, reimbursement policies, and population wealth.

Market Scope’s “2021 Dry Eye Products Market Report” analyzes the current marketplace and forecasts market performance over the next five years. The report examines dry eye syndrome’s etiology, diagnosis, and treatment; the prevalence of dry eye; Rx therapeutics for dry eye; over-the-counter lubricants; thermal expression, IPL, and punctum plugs; and additional dry eye procedures and products. It also includes profiles of the companies that make and distribute dry eye products.

Market Scope’s "2021 Retinal Disease Model" offers extensive country-level prevalence data and five-year forecasts for retinal diseases and conditions by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our US Retina Surgery Quarterly Updates. These updates are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors’ evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.